LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lucrin depot leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe

abbvie pty ltd - leuprorelin acetate, quantity: 3.75 mg - injection, powder for - excipient ingredients: carmellose sodium; mannitol; polysorbate 80; glacial acetic acid; water for injections

LUCRIN DEPOT leuprorelin acetate 11.25mg powder for injection prefilled dual-chamber syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lucrin depot leuprorelin acetate 11.25mg powder for injection prefilled dual-chamber syringe

abbvie pty ltd - leuprorelin acetate, quantity: 11.25 mg - injection, powder for - excipient ingredients: carmellose sodium; polysorbate 80; mannitol; glacial acetic acid; water for injections

Lutrate Depot 22.5mg powder and solvent for prolonged-release suspension for injection Reino Unido - inglês - myHealthbox

lutrate depot 22.5mg powder and solvent for prolonged-release suspension for injection

gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.

ELIGARD 22.5 MG Israel - inglês - Ministry of Health

eligard 22.5 mg

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

ELIGARD 45 MG Israel - inglês - Ministry of Health

eligard 45 mg

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

ELIGARD 7.5 MG Israel - inglês - Ministry of Health

eligard 7.5 mg

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - eligard 7.5 mg is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer combination with radiotherapy.

ELIGARD ® POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 22.5mg Cingapura - inglês - HSA (Health Sciences Authority)

eligard ® powder and solvent for solution for injection 22.5mg

dch auriga singapore - leuprorelin 20.87 mg eqv to leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 22.5 mg - leuprorelin 20.87 mg eqv to leuprorelin acetate 22.5 mg

ELIGARD ® POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 45mg Cingapura - inglês - HSA (Health Sciences Authority)

eligard ® powder and solvent for solution for injection 45mg

dch auriga singapore - leuprorelin 41.7 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 45mg - leuprorelin 41.7 mg eqv leuprorelin acetate 45mg

ELIGARD ® POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 7.5mg Cingapura - inglês - HSA (Health Sciences Authority)

eligard ® powder and solvent for solution for injection 7.5mg

dch auriga singapore - leuprorelin 6.96 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 7.5 mg - leuprorelin 6.96 mg eqv leuprorelin acetate 7.5 mg

Lucrin Depot for Injection PDS 30mg Cingapura - inglês - HSA (Health Sciences Authority)

lucrin depot for injection pds 30mg

abbvie pte. ltd. - leuprorelin acetate - injection, powder, for solution - 30mg - leuprorelin acetate 30mg